MDPHP is thought to act generally for a strong norepinephrine-dopamine reuptake inhibitor (NDRI). Minimized re-uptake of norepinephrine and dopamine leads to better concentrations of the two catecholamine neurotransmitters while in the synaptic cleft, or hole between neurons. The result of this inhibition is surely an Increased and prolonged focus … Read More